Ulrich Laufs

11 ta ish

Oslo University Hospital

1. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

   Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons +97

   MaqolaOAOchiq kirish20215 iqtibos

   ABIABI:AkademIndex/2026.other.072451

2. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

   François Mach, Colin Baigent, Alberico L. Catapano +96

   Sharh maqolaOAOchiq kirish20194 iqtibos

   ABIABI:AkademIndex/2026.other.057765

3. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

   Antonio J. Vallejo‐Vaz, Asif Akram, Sreenivasa Rao Kondapally Seshasai +69

   MaqolaOAOchiq kirish20163 iqtibos

   ABIABI:AkademIndex/2026.other.011186

4. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

   Kanika Dharmayat, Antonio J. Vallejo‐Vaz, Christophe Stevens +97

   MaqolaOAOchiq kirish20233 iqtibos

   ABIABI:AkademIndex/2026.other.233436

5. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

   Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini +37

   Sharh maqola20153 iqtibos

   ABIABI:AkademIndex/2026.other.568881

6. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

   Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens +82

   MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthAtherosclerosis20182 iqtibos

   ABIABI:AkademIndex/2018.article.000004

7. Familial hypercholesterolaemia: A global call to arms

   Antonio J. Vallejo‐Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole +44

   MaqolaOAOchiq kirish20152 iqtibos

   ABIABI:AkademIndex/2026.other.011143

8. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

   Jan Borén, M. John Chapman, Ronald M. Krauss +27

   MaqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.057777

9. Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)

   Rainer Schulz, Klaus‐Dieter Schlüter, Ulrich Laufs

   Sharh maqolaOAOchiq kirish20152 iqtibos

   ABIABI:AkademIndex/2026.other.216528

10. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

    Amany Elshorbagy, Antonio J. Vallejo‐Vaz, Fotios Barkas +80

    MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthEuropean Heart Journal20251 iqtibos

    ABIABI:AkademIndex/2025.article.000498

11. Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics

    Christian Bork, Børge G. Nordestgaard, Berit Storgaard Hedegaard +67

    MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthAtherosclerosis20260 iqtibos

    ABIABI:AkademIndex/2026.article.020412